T-cell acute lymphoblastic leukemia with add(1)(p36) and del(12)(p11) following acute myelocytic leukemia with partial deletion of 9p

Cancer Genetics and Cytogenetics

Volumn 150, Issue 1, 2004, Pages 62-65

  Yoshida, Chikashi ^a   Suzukawa, Kazumi ^a   Katsura, Yukitaka ^a   Shimizu, Seiichi ^a   Mukai, Harumi Y ^a   Hasegawa, Yuichi ^a   Imagawa, Shigehiko ^a   Kojima, Hiroshi ^a   Nagasawa, Toshiro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; IDARUBICIN; MITOXANTRONE; PREDNISONE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLELE; ARTICLE; BRAIN HEMORRHAGE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GENETICS; CANCER PATIENT; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CHROMOSOME DELETION; CHROMOSOME DELETION 12P; CHROMOSOME DELETION 1P; CHROMOSOME DELETION 9; CLINICAL FEATURE; CYTOGENETICS; DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOSS; HUMAN; HUMAN TISSUE; KARYOTYPING; LABORATORY TEST; LEUKEMIA CELL; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; T CELL LEUKEMIA; TREATMENT OUTCOME;

ADULT; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 9; FATAL OUTCOME; GENES, P16; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, T-CELL, ACUTE; MALE; NEOPLASM RECURRENCE, LOCAL; REMISSION INDUCTION;

EID: 1642315393     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2003.08.003     Document Type: Article

References (21)

1. Lai J.L., Fenaux P., Pollet J.P., Estienne M.H., Savary J.B., Huart J.J., Deminatti M. Acute lymphocytic leukemia with 9p anomalies: a report of four additional cases and review of the literature. Cancer Genet Cytogenet. 33:1988;99-109.
2. Baccichet A., Qualman S.K., Sinnett D. Allelic loss in childhood acute lymphoblastic leukemia. Leuk Res. 21:1997;817-823.
3. Takeuchi S., Bartram C.R., Wada M., Reiter A., Hatta Y., Seriu T., Lee E., Miller C.W., Miyoshi I., Koeffler H.P. Allelotype analysis of childhood acute lymphoblastic leukemia. Cancer Res. 55:1995;5377-5382.
4. Chilcote R.R., Brown E., Rowley J.D. Lymphoblastic leukemia with lymphomatous features associated with abnormalities of the short arm of chromosome 9. N Engl J Med. 313:1985;286-291.
5. Kowalczyk J., Sandberg A.A. A possible subgroup of ALL with 9p. Cancer Genet Cytogenet. 9:1983;383-385.
6. Pollak C., Hagemeijer A. Abnormalities of the short arm of chromosome 9 with partial loss of material in hematological disorders. Leukemia. 1:1987;541-548.
7. Guidal-Giroux C., Gerard B., Cave H., Duval M., Rohrlich P., Elion J., Vilmer E., Grandchamp B. Deletion mapping indicates that MTS1 is the target of frequent deletions at chromosome 9p21 in paediatric acute lymphoblastic leukaemias. Br J Haematol. 92:1996;410-419.
8. Aguiar R.C., Sill H., Goldman J.M., Cross N.C. The commonly deleted region at 9p21-22 in lymphoblastic leukemias spans at least 400 kb and includes p16 but not p15 or the IFN gene cluster. Leukemia. 11:1997;233-238.
9. Drexler H.G. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia. 12:1998;845-859.
10. ARF locus deletion and MDM-2 protein expression in adult acute myelogenous leukemia. Cancer. 89:2000;1976-1982.
11. Kaleem Z., Crawford E., Pathan M.H., Jasper L., Covinsky M.A., Johnson L.R., White G. Flow cytometric analysis of acute leukemias: diagnostic utility and critical analysis of data. Arch Pathol Lab Med. 127:2003;42-48.
12. Saxena A., Sheridan D.P., Card R.T., McPeek A.M., Mewdell C.C., Skinnider L.F. Biologic and clinical significance of CD7 expression in acute myeloid leukemia. Am J Hematol. 58:1998;278-284.
13. Pedersen-Bjergaard J., Philip P., Larsen S.O., Andersson M., Daugaard G., Ersboll J., Hansen S.W., Hou-Jensen K., Nielsen D., Sigsgaard T.C., Specht L., Osterlind K. Therapy-related myelodysplasia and acute myeloid leukemia: cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia. 7:1993;1975-1986.
14. Liso V., Specchia G., Pannunzio A., Mestice A., Palumbo G., Biondi A. T-cell acute lymphoblastic leukemia occurring in a patient with acute promyelocytic leukemia. Haematologica. 83:1998;471-473.
15. Tsuboi K., Komatsu H., Miwa H., Iida S., Banno S., Wakita A., Nitta M., Ueda R. T-cell acute lymphoblastic leukemia as a secondary leukemia after a 3-year remission of acute myelocytic leukemia. Int J Hematol. 77:2003;518-521.
16. Lounici A., Cony-Makhoul P., Dubus P., Lacombe F., Merlio J.P., Reiffers J. Lineage switch from acute myeloid leukemia to acute lymphoblastic leukemia: report of an adult case and review of the literature. Am J Hematol. 65:2000;319-321.
17. Gagnon G.A., Childs C.C., LeMaistre A., Keating M., Cork A., Trujillo J.M., Nellis K., Freireich E., Stass S.A. Molecular heterogeneity in acute leukemia lineage switch. Blood. 74:1989;2088-2095.
18. Raimondi S.C. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood. 81:1993;2237-2251.
19. Filatov L.V., Saito M., Behm F.G., Rivera G.K., Raimondi S.C. A subtle deletion of 12p by routine cytogenetics is found to be a translocation to 21q by fluorescence in situ hybridization: t(12;21)(p13;q22). Cancer Genet Cytogenet. 89:1996;136-140.
20. Romana S.P., Le Coniat M., Poirel H., Marynen P., Bernard O., Berger R. Deletion of the short arm of chromosome 12 is a secondary event in acute lymphoblastic leukemia with t(12;21). Leukemia. 10:1996;167-170.
21. Raimondi S.C., Shurtleff S.A., Downing J.R., Rubnitz J., Mathew S., Hancock M., Pui C.H., Rivera G.K., Grosveld G.C., Behm F.G. 12p abnormalities and the TEL gene (ETV6) in childhood acute lymphoblastic leukemia. Blood. 90:1997;4559-4566.